Cargando…
Apolipoprotein E ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
Alzheimer’s disease (AD) displays a high degree of heterogeneity in terms of its etiology, presentation, prognosis, and treatment response. This can partly be explained by high-penetrance mutations in the amyloid precursor protein, presenilin 1 and presenilin 2 genes causing amyloid beta aggregation...
Autores principales: | Kotze, MJ, Lückhoff, HK, Brand, T, Pretorius, J, van Rensburg, SJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337157/ https://www.ncbi.nlm.nih.gov/pubmed/32669910 http://dx.doi.org/10.2147/DNND.S41721 |
Ejemplares similares
-
Apolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months
por: Regal, Paul, et al.
Publicado: (2013) -
A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex–associated Alzheimer's disease
por: Lopatko Lindman, Karin, et al.
Publicado: (2019) -
Genetic influence of Apolipoprotein E gene ε2/ε3/ε4 isoforms on odds of mesial temporal lobe epilepsy
por: Xu, Tao, et al.
Publicado: (2021) -
Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer’s disease
por: López-Riquelme, Natividad, et al.
Publicado: (2016) -
Sex differences in the association between apolipoprotein E ε4 allele and Alzheimer's disease markers
por: Sundermann, Erin E., et al.
Publicado: (2018)